Wolverine Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Wolverine Asset Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20,900	Closed	-$30K	–	1911
2015 Q4	$30K	Sell	20,900 -9,000	-30%	-$12.9K	﹤0.01%	1246
2015 Q3	$47K	Hold	29,900	–	–	﹤0.01%	1286
2015 Q2	$50K	Buy	+29,900	New	+$50K	﹤0.01%	1307
2015 Q1	–	Sell	-138,200	Closed	-$208K	–	2493
2014 Q4	$208K	Buy	138,200 +30,700	+29%	+$46.2K	﹤0.01%	945
2014 Q3	$221K	Buy	107,500 +27,100	+34%	+$55.7K	﹤0.01%	1014
2014 Q2	$246K	Buy	+80,400	New	+$246K	0.01%	846

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Wolverine Asset Management's RXII Position: Q1 2016 in Review

Wolverine Asset Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2016, closing a stake of 20,900 shares — an estimated $30K sold.

Wolverine Asset Management first reported a position in RXII in Q2 2014 and held it in 6 quarters. The position peaked at $246K in Q2 2014. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

Wolverine Asset Management reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2016 after selling out during the quarter.
Wolverine Asset Management sold 20,900 GALENA BIOPHARMA INC COM shares in Q1 2016, an estimated $30K.
Wolverine Asset Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 6 quarters.
Wolverine Asset Management's GALENA BIOPHARMA INC COM position peaked at $246K in Q2 2014.
71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on Wolverine Asset Management's 13F filing for Q1 2016, filed 16 May 2016.